Showing results (2061-2070 of 2,072) with videos related to

Sort By:
Pageof 208
JAMA|December 10, 2020
Effect of Capecitabine Maintenance Therapy Using Lower Dosage and Higher Frequency vs Observation on Disease-Free Survival Among Patients With Early-Stage Triple-Negative Breast Cancer Who Had Received Standard Treatment: The SYSUCC-001 Randomized Clinical TrialXi Wang, Shu-Sen Wang, Heng Huang, et al.
Platelets|July 3, 2020
Risk stratification and outcomes of intracranial hemorrhage in patients with immune thrombocytopenia under 60 years of agePeng Zhao, Ming Hou, Yi Liu, et al.
Breast Cancer (Dove Medical Press)|April 17, 2024
Does the Dose of Standard Adjuvant Chemotherapy Affect the Triple-negative Breast Cancer Benefit from Extended Capecitabine Metronomic Therapy? An Exploratory Analysis of the SYSUCC-001 TrialYing Chen, Wen-Xia Li, Jia-Hua Wu, et al.
Proceedings of the National Academy of Sciences of the United States of America|April 6, 2022
Transcriptome-wide subtyping of pediatric and adult T cell acute lymphoblastic leukemia in an international study of 707 casesYu-Ting Dai, Fan Zhang, Hai Fang, et al.
Blood Advances|June 9, 2022
Developing and validating a mortality prediction model for ICH in ITP: a nationwide representative multicenter studyShan Chong, Peng Zhao, Rui-Bin Huang, et al.
International Journal of Hematology|April 6, 2018
Chinese guidelines for treatment of adult primary immune thrombocytopeniaXin-Guang Liu, Xiao-Chuan Bai, Fang-Ping Chen, et al.
The Lancet. Oncology|December 28, 2019
Genetic risk of extranodal natural killer T-cell lymphoma: a genome-wide association study in multiple populationsGuo-Wang Lin, Caigang Xu, Kexin Chen, et al.
The Lancet. Oncology|July 30, 2016
Genetic risk of extranodal natural killer T-cell lymphoma: a genome-wide association studyZheng Li, Yi Xia, Li-Na Feng, et al.
World Journal of Gastroenterology|November 19, 2025
Development of a deep learning model for guiding treatment decisions of acute variceal bleeding in patients with cirrhosisYi Xiang, Na Yang, Tian-Lei Zheng, et al.
Frontiers in Oncology|October 12, 2020
Survival Benefit and Genetic Profile of Pemetrexed as Initial Chemotherapy in Selected Chinese Patients With Advanced Lung AdenocarcinomaLong-Hua Guo, Ming-Feng Zhang, He-Long Zhang, et al.
Pageof 208